BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ceftibuten

A cephalosporin antibacterial agent that is used in the treatment of infections, including urinary-tract and respiratory-tract infections.

299+ PubMed studies analyzed · 40 RCTs · Evidence Score: 48.5

Research Domains

Ceftibuten has been studied across 10 research domains including 🦠 Gut & Microbiome, 🧠 Focus & Attention, 🫁 Respiratory, 🫘 Kidney, 🔥 Metabolic. The primary research focus is 🦠 Gut & Microbiome with 12% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ceftibuten, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Cefpodoxime
2 shared targets
cefatrizine
2 shared targets
silver
2 shared targets
Cefmenoxime
2 shared targets
ceftazidime
2 shared targets
Cephaloglycin
2 shared targets
Cefoxitin
2 shared targets
Cefazolin
2 shared targets
Dipyrone
2 shared targets
Dithiazanine
2 shared targets
Loading evidence profile...

This evidence profile for Ceftibuten is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.